摘要

Phospholipase D (PLD) is involved in many biological processes. PLD1 plays a crucial role in regulating the platelet activity of mice; however, the role of PLD in the platelet activation of humans remains unclear. Therefore, we investigated whether PLD is involved in the platelet activation of humans. Our data revealed that inhibition of PLD1 or PLD2 using pharmacological inhibitors effectively inhibits platelet aggregation in humans. However, previous studies have showed that PLD1 or PLD2 deletion did not affect mouse platelet aggregation in vitro, whereas only PLD1 deletion inhibited thrombus formation in vivo. Intriguingly, our data also showed that the pharmacological inhibition of PLD1 or PLD2 does not affect mouse platelet aggregation in vitro, whereas the inhibition of only PLD1 delayed thrombus formation in vivo. These findings indicate that PLD may play differential roles in humans and mice. In humans, PLD inhibition attenuates platelet activation, adhesion, spreading, and clot retraction. For the first time, we demonstrated that PLD1 and PLD2 are essential for platelet activation in humans, and PLD plays different roles in platelet function in humans and mice. Our findings also indicate that targeting PLD may provide a safe and alternative therapeutic approach for preventing thromboembolic disorders
原文英語
期刊Journal of Clinical Medicine
7
發行號11
DOIs
出版狀態已發佈 - 十一月 14 2018

指紋

Phospholipase D
Blood Platelets
Platelet Activation
Platelet Aggregation
Thrombosis
Clot Retraction
Pharmacology
Biological Phenomena

Keywords

  • phospholipase D
  • platelet activation
  • clot retraction
  • thrombus formation

引用此文

An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets. / Lu, Wan Jung; Chung, Chi Li; Chen, Ray Jade; Huang, Li Ting; Lien, Li Ming; Chang, Chao Chien; Lin, Kuan Hung; Sheu, Joen Rong.

於: Journal of Clinical Medicine, 卷 7, 編號 11, 14.11.2018.

研究成果: 雜誌貢獻文章

@article{b551537f981a4341a884a72402043430,
title = "An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets",
abstract = "Phospholipase D (PLD) is involved in many biological processes. PLD1 plays a crucial role in regulating the platelet activity of mice; however, the role of PLD in the platelet activation of humans remains unclear. Therefore, we investigated whether PLD is involved in the platelet activation of humans. Our data revealed that inhibition of PLD1 or PLD2 using pharmacological inhibitors effectively inhibits platelet aggregation in humans. However, previous studies have showed that PLD1 or PLD2 deletion did not affect mouse platelet aggregation in vitro, whereas only PLD1 deletion inhibited thrombus formation in vivo. Intriguingly, our data also showed that the pharmacological inhibition of PLD1 or PLD2 does not affect mouse platelet aggregation in vitro, whereas the inhibition of only PLD1 delayed thrombus formation in vivo. These findings indicate that PLD may play differential roles in humans and mice. In humans, PLD inhibition attenuates platelet activation, adhesion, spreading, and clot retraction. For the first time, we demonstrated that PLD1 and PLD2 are essential for platelet activation in humans, and PLD plays different roles in platelet function in humans and mice. Our findings also indicate that targeting PLD may provide a safe and alternative therapeutic approach for preventing thromboembolic disorders.",
keywords = "phospholipase D, platelet activation, clot retraction, thrombus formation",
author = "Lu, {Wan Jung} and Chung, {Chi Li} and Chen, {Ray Jade} and Huang, {Li Ting} and Lien, {Li Ming} and Chang, {Chao Chien} and Lin, {Kuan Hung} and Sheu, {Joen Rong}",
year = "2018",
month = "11",
day = "14",
doi = "10.3390/jcm7110440",
language = "English",
volume = "7",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "MDPI AG",
number = "11",

}

TY - JOUR

T1 - An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets

AU - Lu, Wan Jung

AU - Chung, Chi Li

AU - Chen, Ray Jade

AU - Huang, Li Ting

AU - Lien, Li Ming

AU - Chang, Chao Chien

AU - Lin, Kuan Hung

AU - Sheu, Joen Rong

PY - 2018/11/14

Y1 - 2018/11/14

N2 - Phospholipase D (PLD) is involved in many biological processes. PLD1 plays a crucial role in regulating the platelet activity of mice; however, the role of PLD in the platelet activation of humans remains unclear. Therefore, we investigated whether PLD is involved in the platelet activation of humans. Our data revealed that inhibition of PLD1 or PLD2 using pharmacological inhibitors effectively inhibits platelet aggregation in humans. However, previous studies have showed that PLD1 or PLD2 deletion did not affect mouse platelet aggregation in vitro, whereas only PLD1 deletion inhibited thrombus formation in vivo. Intriguingly, our data also showed that the pharmacological inhibition of PLD1 or PLD2 does not affect mouse platelet aggregation in vitro, whereas the inhibition of only PLD1 delayed thrombus formation in vivo. These findings indicate that PLD may play differential roles in humans and mice. In humans, PLD inhibition attenuates platelet activation, adhesion, spreading, and clot retraction. For the first time, we demonstrated that PLD1 and PLD2 are essential for platelet activation in humans, and PLD plays different roles in platelet function in humans and mice. Our findings also indicate that targeting PLD may provide a safe and alternative therapeutic approach for preventing thromboembolic disorders.

AB - Phospholipase D (PLD) is involved in many biological processes. PLD1 plays a crucial role in regulating the platelet activity of mice; however, the role of PLD in the platelet activation of humans remains unclear. Therefore, we investigated whether PLD is involved in the platelet activation of humans. Our data revealed that inhibition of PLD1 or PLD2 using pharmacological inhibitors effectively inhibits platelet aggregation in humans. However, previous studies have showed that PLD1 or PLD2 deletion did not affect mouse platelet aggregation in vitro, whereas only PLD1 deletion inhibited thrombus formation in vivo. Intriguingly, our data also showed that the pharmacological inhibition of PLD1 or PLD2 does not affect mouse platelet aggregation in vitro, whereas the inhibition of only PLD1 delayed thrombus formation in vivo. These findings indicate that PLD may play differential roles in humans and mice. In humans, PLD inhibition attenuates platelet activation, adhesion, spreading, and clot retraction. For the first time, we demonstrated that PLD1 and PLD2 are essential for platelet activation in humans, and PLD plays different roles in platelet function in humans and mice. Our findings also indicate that targeting PLD may provide a safe and alternative therapeutic approach for preventing thromboembolic disorders.

KW - phospholipase D

KW - platelet activation

KW - clot retraction

KW - thrombus formation

U2 - 10.3390/jcm7110440

DO - 10.3390/jcm7110440

M3 - Article

C2 - 30441821

VL - 7

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 11

ER -